Monitor the latest Covid-19 Data and Information in Indonesia on microsite Katadata ini.
Various countries are competing to develop coronavirus vaccine. The vaccine is considered capable of being terminated pandemic which has been running for eight months.
However, Head of the Eijkman Institute for Molecular Biology Amin Soebandrio said world production capacity would not be able to meet vaccine needs. Covid-19 globaly. This is because the existing production facilities are only able to meet the vaccine needs of 50% of the world’s population.
What’s more, many countries are unable or unwilling to produce vaccines independently. One of the considerations is economic factors.
With such conditions, Amin also appealed to all levels of society to support the independence of the Covid-19 vaccine. This is important to ensure the fulfillment of vaccine needs for all Indonesian people.
Moreover, Indonesia’s vaccine needs are quite high. To achieve herd immunity or herd immunity, the vaccination program must reach 70% of the population.
With a population of around 260 million in Indonesia, the vaccination program must be accepted by 175 million people. That means, the government must provide 350 million vaccines because it takes two injections in the Covid-19 vaccination program.
This large amount, continued Amin, would not be fulfilled by simply relying on the production capacity of vaccines from abroad. “We must have the ability to make our own vaccines,” Amin said as quoted from Among on Thursday (5/12).
Eijkman together with Bio Farma and Sinovac, as well as research institutes and universities in Indonesia are developing the Red and White vaccine. The Covid-19 vaccine is in the third phase of clinical trials scheduled for completion at the end of December 2020.
In the next stage, Bio Farma reports the results of clinical trials to the Food and Drug Administration (BPOM). The institution will later decide to grant distribution permits or not for the Red and White vaccine.
If a distribution permit is issued, the Red and White vaccine can begin to be produced and distributed in January 2020. While waiting for the Covid-19 vaccine, the Covid-19 Handling Task Force urges the public to comply with health protocols by using masks, washing hands, and maintaining distance to reduce transmission of the corona virus. .
– .
